Sex bias in preclinical research and an exploration of how to change the status quo
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
There has been a revolution within clinical trials to include females in the research pipeline. However, there has been limited change in the preclinical arena; yet the research here lays the ground work for the subsequent clinical trials. Sex bias has been highlighted as one of the contributing factors to the poor translation and replicability issues undermining preclinical research. There have been multiple calls for action, and the funders of biomedical research are actively pushing the inclusion of sex as a biological variable. Here, we consider the current standard practice within the preclinical research setting, why there is a movement to include females and why the imbalance exists. We explore organizational change theory as a tool to shape strategies needed at an individual and institute level to change the status quo. The ultimate goal is to create a scientific environment in which our preclinical research automatically implements sex‐sensitive approaches. LINKED ARTICLES: This article is part of a themed section on The Importance of Sex Differences in Pharmacology Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.21/issuetoc
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Policy: NIH to balance sex in cell and animal studies
Clayton, J. A., & Collins, F. S. (2014) · Nature · doi:10.1038/509282a · Cited by 1,816 · cited 3×
“The NIH now require applicants to report their plans for including sex as a biological variable in studies involving animals or cell lines, ‘unless sexspecific inclusion is unwarranted based on rigorously defined exceptions’ (Clayton and Collins, 2014).”
BackgroundSex bias in neuroscience and biomedical research
Beery, A. K., & Zucker, I. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.002 · Cited by 1,763
The Extent and Consequences of P-Hacking in Science
Head, M. L., Holman, L., Lanfear, R., Kahn, A. T., & Jennions, M. D. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002106 · Cited by 1,388 · cited 1×
“This will also address the issue of ‘p-hacking’ or ‘data-dredging’ which is the process of amending your statistical plan until statistical significance is obtained which is recognized to contribute to the replication crisis (Head et al., 2015).”
BackgroundPolicy: NIH plans to enhance reproducibility
Collins, F. S., & Tabak, L. A. (2014) · Nature · doi:10.1038/505612a · Cited by 1,247 · cited 2×
“The failure to acknowledge a potential sex difference has been highlighted as one of the possible contributing factors to the failure of replication undermining science and the translational crisis which questions the value of the preclinical research (Collins and Tabak, 2014).”
Gigerenzer, G. (2004) · The Journal of Socio-Economics · doi:10.1016/j.socec.2004.09.033 · Cited by 890
Kilkenny, C., Parsons, N., Kadyszewski, E., Festing, M. F. W., Cuthill, I. C., Fry, D., Hutton, J., & Altman, D. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007824 · Cited by 860
Female mice liberated for inclusion in neuroscience and biomedical research
Prendergast, B. J., Onishi, K. G., & Zucker, I. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.001 · Cited by 788
Design, power, and interpretation of studies in the standard murine model of ALS
Scott, S., Kranz, J. E., Cole, J., Lincecum, J. M., Thompson, K., Kelly, N., Bostrom, A., Theodoss, J., Al‐Nakhala, B. M., Vieira, F. G., et al. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701856300 · Cited by 504 · cited 1×
“In a study considering the low success rate in clinical trial of treatments for motor neuron disease, the authors demonstrated the importance of controlling confounders such as sex for reproducible and translatable research (Scott et al., 2008).”
BackgroundThe Anatomy of Medical Research: US and International Comparisons
Moses, H., Matheson, D. H. M., Cairns-Smith, S., George, B. P., Palisch, C., & Dorsey, E. R. (2015) · JAMA · doi:10.1001/jama.2014.15939 · Cited by 446 · cited 1×
“As the NIH are the largest funders of biomedical research in the world (Moses et al., 2015) and it was anticipated that this initiative would lead to a shift in research practice.”
BackgroundRisk of bias in reports of in vivo research: a focus for improvement
Macleod, M. R., Lawson McLean, A., Kyriakopoulou, A., Serghiou, S., de Wilde, A., Sherratt, N., Hirst, T., Hemblade, R., Bahor, Z., Nunes-Fonseca, C., et al. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002273 · Cited by 358 · cited 1×
“However, reporting rates of key strategies to improve experiments are improving (Macleod et al., 2015).”
BackgroundBaker, D., Lidster, K., Sottomayor, A., & Amor, S. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001756 · Cited by 305
Sex bias exists in basic science and translational surgical research
Yoon, D. Y., Mansukhani, N. A., Stubbs, V. C., Helenowski, I. B., Woodruff, T. K., & Kibbe, M. R. (2014) · Surgery · doi:10.1016/j.surg.2014.07.001 · Cited by 270
Prevalence of sexual dimorphism in mammalian phenotypic traits
Karp, N. A., Mason, J., Beaudet, A. L., Benjamini, Y., Bower, L., Braun, R. E., Brown, S. D. M., Chesler, E. J., Dickinson, M. E., Flenniken, A. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15475 · Cited by 257 · cited 2×
“Research from the International Mouse Phenotyping Consortium (IMPC) looking at data from 10 institutes, 14 thousand wildtype mice, 40 thousand knockout mice for 234 traits found that sex was a significant source of variation within control data and as a modifier of a treatment effect (Karp et al., 2017).”
BackgroundSelf-citationDo you know the sex of your cells?
Shah, K., McCormack, C. E., & Bradbury, N. A. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00281.2013 · Cited by 219
Bias in the reporting of sex and age in biomedical research on mouse models
Flórez-Vargas, O., Brass, A., Karystianis, G., Bramhall, M., Stevens, R., Cruickshank, S., & Nenadic, G. (2016) · eLife · doi:10.7554/elife.13615 · Cited by 124 · cited 1×
“Research has found mixed results on the outcomes of the guidelines on the quality of reporting (Baker et al., 2014; Flórez-Vargas et al., 2016; Sena, 2017).”
ResultThe Experimental Design Assistant
Percie du Sert, N., Bamsey, I., Bate, S. T., Berdoy, M., Clark, R. A., Cuthill, I., Fry, D., Karp, N. A., Macleod, M., Moon, L., et al. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2003779 · Cited by 118
Self-citationThe researchers’ view of scientific rigor—survey on the conduct and reporting of in vivo research
Reichlin, T. S., Vogt, L., & Würbel, H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0165999 · Cited by 72 · cited 3×
“A survey assessing researchers’ views on scientific rigour found that many scientists were not following recommended practice because they did not perceive it was relevant to their situation (Reichlin et al., 2016).”
BackgroundInfluential
Cited by
Reproducibility of animal research in light of biological variation
Voelkl, B., Altman, N. S., Forsman, A., Forstmeier, W., Gurevitch, J., Jaric, I., Karp, N. A., Kas, M. J., Schielzeth, H., Van de Casteele, T., et al. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0313-3 · Cited by 390
Self-citation
Metadata
- Authors
- Karp, N. A., & Reavey, N.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2018-12-12
- Volume
- 176
- Issue
- 21
- Pages
- 4107-4118
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2901904590
- Cited by
- 159
- References
- 19
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.